First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial
Karim Fizazi, Arun A. Azad, Nobuaki Matsubara et al. · Nature Medicine · 2023 · Randomised trial
Full textCC BY
Medicine: papers
Filters2 filters applied
Status
- Corrected
- No notice
- Not checked
- From publisher notices and Retraction Watch. Not checked means nobody has looked yet.
Study type
2 papersQuestions on this topic
Corrected Corrected Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial
Nadia Harbeck, Eva Ciruelos, Guy Jerusalem et al. · Nature Medicine · 2024
Full textCC BY